Universal Brain received FDA 510(k) clearance for its UB ERP System, a platform that measures brain function using EEG and event-related potentials. The system pairs a dry-electrode headset with software that captures neural responses as patients complete cognitive and emotional tasks, producing analyzed results in under five minutes. Psychiatry traditionally relies on symptom-based evaluation, with few objective tools. Universal Brain positions its approach as a way to bring physiological measurement into treatment selection and CNS drug trials. The company is preparing a commercial launch later in 2026.